Literature DB >> 33960747

Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST).

Luca Stingeni1, Leonardo Bianchi2, Iris Zalaudek3, Paolo D Pigatto4, Ketty Peris5, Cataldo Patruno6, Gabriella Fabbrocini7, Giuseppe Micali8, Maddalena Napolitano9, Marta Tramontana1, Katharina Hansel1.   

Abstract

Year:  2021        PMID: 33960747     DOI: 10.23736/S2784-8671.21.06992-3

Source DB:  PubMed          Journal:  Ital J Dermatol Venerol        ISSN: 2784-8671


× No keyword cloud information.
  6 in total

Review 1.  A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

Authors:  Farnoosh Seirafianpour; Homa Pourriyahi; Milad Gholizadeh Mesgarha; Arash Pour Mohammad; Zoha Shaka; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2022-04-11       Impact factor: 3.858

2.  Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series.

Authors:  Fabrizio Martora; Gabriella Fabbrocini; Claudio Marasca
Journal:  Dermatol Ther       Date:  2021-12-01       Impact factor: 3.858

3.  Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.

Authors:  Teresa Grieco; Patrizia Maddalena; Alvise Sernicola; Rovena Muharremi; Stefania Basili; Domenico Alvaro; Roberto Cangemi; Alfredo Rossi; Giovanni Pellacani
Journal:  Dermatol Ther       Date:  2021-10-13       Impact factor: 3.858

4.  Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.

Authors:  Massimo Dell'Antonia; Speranza Anedda; Federica Usai; Laura Atzori; Caterina Ferreli
Journal:  Dermatol Ther       Date:  2021-11-30       Impact factor: 3.858

Review 5.  Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.

Authors:  T Gambichler; S Boms; L Susok; H Dickel; C Finis; N Abu Rached; M Barras; M Stücker; D Kasakovski
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-11-02       Impact factor: 9.228

6.  Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: A real life experience.

Authors:  Maria Letizia Musumeci; Giuliana Caruso; Andrea Calogero Trecarichi; Giuseppe Micali
Journal:  Dermatol Ther       Date:  2021-11-15       Impact factor: 3.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.